Follicle-stimulating hormone accelerates osteoclast migration by enhancing methyltransferase-like 3-mediated m6A methylation of cathepsin K
Journal of Molecular Endocrinology · 23.01.2024 · 72 (3)
DOI: 10.1530/jme-23-0130 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Molecular Endocrinology, erschienen am 23.01.2024. Verfasst von Xiaosa Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Guangzhou Institute of Cardiovascular Disease, Guangdong Key Laboratory of Vascular Diseases, the Second Affiliated Hospita…. Hauptthemen laut MEDLINE: Osteoclasts, Osteoporosis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 55 Literaturangaben.
Abstract (Originalsprache)
Follicle-stimulating hormone (FSH) accelerates osteoporosis in postmenopausal women, while the underlying mechanism remains uncharacterized. N6-methyladenosine (m6A) is one of the most important regulations in the development of osteoporosis. In this study, we aimed to investigate the role of FSH in m6A modification and osteoclast function. Here, we showed that FSH upregulated m6A levels in osteoclasts via stimulating methyltransferase-like 3 (METTL3) protein expression. FSH enhanced osteoclast migration, while the knockdown of METTL3 eliminated this enhancement. Both MeRIP-seq and RNA sequencing identified that cathepsin K (CTSK) is the potential downstream target of METTL3. Knockdown of CTSK reduced FSH-upregulated osteoclast migration. Furthermore, silencing METTL3 decreased CTSK mRNA stability. Finally, FSH induced phosphorylation of cyclic-AMP response element-binding protein (CREB), while silencing of CREB attenuated the effects of FSH on the promoter transcriptional activity of Mettl3 and CTSK/METTL3 protein. Taken together, these findings indicate that FSH promotes osteoclast migration via the CREB/METTL3/CTSK signaling pathway, which may provide a potential target for suppressing osteoclast mobility and postmenopausal osteoporosis therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Guangzhou Institute of Cardiovascular Disease, Guangdong Key Laboratory of Vascular Diseases, the Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
- Guangzhou First People's Hospital, South China University of Technology, Guangzhou, Guangdong, China.
- Qingyuan People's Hospital, The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan, Guangdong, China.
ORCID-Profile: Xiaodong Fu
Zitieren
APA
Li, X., Fan, C., Wang, J., Li, P., Xu, X., Guo, R., Wei, J., Cheng, Y., Lin, H., & Fu, X. (2024). Follicle-stimulating hormone accelerates osteoclast migration by enhancing methyltransferase-like 3-mediated m6A methylation of cathepsin K. Journal of Molecular Endocrinology, 72(3). https://doi.org/10.1530/jme-23-0130
Vancouver
Li X, Fan C, Wang J, Li P, Xu X, Guo R, et al. Follicle-stimulating hormone accelerates osteoclast migration by enhancing methyltransferase-like 3-mediated m6A methylation of cathepsin K. Journal of Molecular Endocrinology. 2024;72(3). doi:10.1530/jme-23-0130
BibTeX
@article{Li2024,
author = {Li, Xiaosa and Fan, Chao and Wang, Jiale and Li, Ping and Xu, Xingyan and Guo, Ruixin and Wei, Jinzhi and Cheng, Yang and Lin, Huiping and Fu, Xiaodong},
title = {Follicle-stimulating hormone accelerates osteoclast migration by enhancing methyltransferase-like 3-mediated m6A methylation of cathepsin K},
journal = {Journal of Molecular Endocrinology},
year = {2024},
volume = {72},
number = {3},
doi = {10.1530/jme-23-0130}
}
EUVIMED